期刊文献+

Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease

下载PDF
导出
摘要 Alzheimer’s disease(AD)is a chronic neurodegenerative disease,which is difficult to diagnose in its early stages.It is associated with aging and consists of a decline in cognitive functions,memory,and other mental activities.Some pathophysiological markers are associated with AD progression and worsening,such as the deposition and intracellular accumulation of senile plaques containing amyloid-β(Aβ)peptides,and tau protein hyperphosphorylation,leading to the formation of neurofibrillary tangles.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2021年第5期990-991,共2页 中国神经再生研究(英文版)
关键词 ALZHEIMER TAU
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部